Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more

Duchenne Muscular Dystrophy Clinical Study

Publication date: 4 Jan 2022

Associated community Muscular Dystrophy, Duchenne and Becker Types


You and your loved one are not alone in managing Duchenne muscular dystrophy. The LELANTOS I study is testing an investigational drug in patients with Duchenne muscular dystrophy who are non-ambulatory. The study is evaluating whether the drug can maintain or improve muscle strength of upper extremities and stabilizing respiratory and heart functions in Duchenne patients. 

Duchenne patients who fit the following criteria may be eligible to participate: 

A Duchenne muscular dystrophy diagnosis

  • Male

  • Aged 12 or older

  • Currently unable to walk without braces or assistive devices

  • On a stable dose of corticosteroids for at least 6 months

Duchenne research can only move forward with volunteers. Answer a few questions to see if you or your loved one is eligible to take part in this clinical study:

Yes, see if I’m eligible!

Thank you for your interest!


View link